Trial Profile
MK-0928 [gaboxadol] phase II sleep laboratory study - primary insomnia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 16 Sep 2006 New trial record.